We then examined the Bcl-2 and Bcl-xL proteins expression in quercetin treated prostate cancer cells, we observed significant decrease of Bcl-2 and Bcl-xL proteins (Fig. 2). This evidence concerns the gene BCL2 and Familial prostate cancer.